Recent research results from China’s financial securities firms show that the estimated cost of the Chinese regime’s mass COVID-19 nucleic acid testing exceeded its military spending in 2021, and that it will drain China’s national medical insurance funds within three and a half years if citizens are tested every two days as required by the regime.
Mainland Chinese news portal Sina.com published the research report by the macro research team of Huachuang Securities on May 23. The report pointed out that according to unofficial statistics, combined with the changes in testing volume and unit price, since the COVID-19 outbreak, the estimated cost of nucleic acid testing has been about 300 billion yuan (about $44.7 billion), of which nearly 150 billion yuan ($22.3 billion) was spent in the first four months of this year.
